Screener
Strata Critical Medical SRTA Preferred Stock, Shares Authorized
Preferred Stock, Shares Authorized at other companies
Other financials
Where this comes from
Reported directly by Strata Critical Medical in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockSharesAuthorized.
The source filing: Strata Critical Medical’s 10-Q, filed May 6, 2026.
- Filed
- May 6, 2026, 11:53 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-031032
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Total liabilities | 41,887 | 46,400 |
| Commitments and Contingencies (Note 12) | ||
| Stockholders' Equity | ||
| Preferred stock, $0.0001 par value, 2,000,000 shares authorized; no shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively | — | — |
| Common stock, $0.0001 par value; 400,000,000 authorized; 86,521,570 and 86,702,183 shares issued at March 31, 2026 and December 31, 2025, respectively | 7 | 7 |
| Additional paid in capital | 429,121 | 424,616 |
| Accumulated other comprehensive income | — | — |
| Accumulated deficit | (143,397) | (145,551) |
Item 1. Financial Statements
FAQ
- What is Strata Critical Medical's preferred stock, shares authorized?
- Strata Critical Medical (SRTA) reported preferred stock, shares authorized of $2M in Q1 2026.
- How has Strata Critical Medical's preferred stock, shares authorized changed year-over-year?
- Strata Critical Medical's preferred stock, shares authorized decreased by 0.0% year-over-year, from $2M to $2M.
- What is the long-term trend for Strata Critical Medical's preferred stock, shares authorized?
- Over 4 years (2021 to 2025), Strata Critical Medical's preferred stock, shares authorized has grown at a 0.0% compound annual growth rate (CAGR), from $2M to $2M.
Ask your AI about Strata Critical Medical's preferred stock, shares authorized.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude